Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7986 USD | +3.71% | -19.33% | +7.92% |
Apr. 08 | ADRs Advance, Eco Wave Power Global AB Climbs 213.4% | DJ |
Apr. 03 | ADRs End Higher, Aesthetic Medical International Holdings Group Ltd. Climbs 35.5% | DJ |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 542.4 | 163.8 | 20.45 | 30.09 | 38.64 | 8.117 |
Enterprise Value (EV) 1 | 409.8 | 126.5 | 30.31 | 27.93 | 53.92 | 9.879 |
P/E ratio | 8.26 x | 33.4 x | -0.29 x | -0.82 x | -1.99 x | -4.31 x |
Yield | 2.39% | - | - | - | - | - |
Capitalization / Revenue | 5.06 x | 2.67 x | 1.79 x | 17.1 x | 6.12 x | 0.62 x |
EV / Revenue | 3.82 x | 2.06 x | 2.65 x | 15.9 x | 8.54 x | 0.75 x |
EV / EBITDA | 5.39 x | 23 x | -0.84 x | -1.03 x | -3.57 x | -0.69 x |
EV / FCF | 8.96 x | 59.1 x | -0.76 x | 6.93 x | -2.29 x | 0.86 x |
FCF Yield | 11.2% | 1.69% | -131% | 14.4% | -43.6% | 117% |
Price to Book | 3.87 x | 1.3 x | 0.43 x | 1.66 x | 3.15 x | 0.93 x |
Nbr of stocks (in thousands) | 15,986 | 16,352 | 16,227 | 17,098 | 22,866 | 22,866 |
Reference price 2 | 33.93 | 10.02 | 1.260 | 1.760 | 1.690 | 0.3550 |
Announcement Date | 7/30/18 | 7/31/19 | 8/14/20 | 7/28/21 | 12/29/22 | 7/14/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 107.3 | 61.33 | 11.44 | 1.755 | 6.311 | 13.18 |
EBITDA 1 | 76.05 | 5.505 | -36.25 | -27.13 | -15.12 | -14.25 |
EBIT 1 | 75.88 | 5.098 | -36.83 | -27.15 | -15.13 | -14.27 |
Operating Margin | 70.74% | 8.31% | -322.05% | -1,547.05% | -239.79% | -108.23% |
Earnings before Tax (EBT) 1 | 76.54 | 7.405 | -66.93 | -31.07 | -16.72 | -13.07 |
Net income 1 | 65.48 | 5.533 | -71.2 | -34.83 | -16.85 | -1.36 |
Net margin | 61.05% | 9.02% | -622.63% | -1,984.52% | -267.01% | -10.32% |
EPS 2 | 4.110 | 0.3000 | -4.381 | -2.139 | -0.8480 | -0.0823 |
Free Cash Flow 1 | 45.76 | 2.141 | -39.83 | 4.03 | -23.51 | 11.54 |
FCF margin | 42.66% | 3.49% | -348.34% | 229.61% | -372.55% | 87.53% |
FCF Conversion (EBITDA) | 60.17% | 38.9% | - | - | - | - |
FCF Conversion (Net income) | 69.88% | 38.7% | - | - | - | - |
Dividend per Share 2 | 0.8100 | - | - | - | - | - |
Announcement Date | 7/30/18 | 7/31/19 | 8/14/20 | 7/28/21 | 12/29/22 | 7/14/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 9.87 | - | 15.3 | 1.76 |
Net Cash position 1 | 133 | 37.4 | - | 2.16 | - | - |
Leverage (Debt/EBITDA) | - | - | -0.2722 x | - | -1.011 x | -0.1236 x |
Free Cash Flow 1 | 45.8 | 2.14 | -39.8 | 4.03 | -23.5 | 11.5 |
ROE (net income / shareholders' equity) | 80.1% | 4.15% | -81.6% | -96.5% | -114% | -124% |
ROA (Net income/ Total Assets) | 49.3% | 1.89% | -18.3% | -30.3% | -23% | -21.4% |
Assets 1 | 132.7 | 292.7 | 389.2 | 115.1 | 73.37 | 6.35 |
Book Value Per Share 2 | 8.760 | 7.710 | 2.960 | 1.060 | 0.5400 | 0.3800 |
Cash Flow per Share 2 | 8.300 | 3.500 | 0.6700 | 0.9300 | 0.9600 | 0.3500 |
Capex 1 | 0.46 | 0.94 | 0.31 | - | 0 | - |
Capex / Sales | 0.43% | 1.54% | 2.75% | - | 0.08% | - |
Announcement Date | 7/30/18 | 7/31/19 | 8/14/20 | 7/28/21 | 12/29/22 | 7/14/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+7.92% | 117M | |
-2.53% | 184B | |
-11.62% | 180B | |
-8.43% | 91.88B | |
+41.15% | 91.6B | |
-10.53% | 71.28B | |
+19.26% | 26.35B | |
+17.48% | 10.05B | |
-11.43% | 8.53B | |
-15.19% | 5.59B |
- Stock Market
- Equities
- AHG Stock
- Financials Akso Health Group